论文部分内容阅读
名 称:普伐他汀钠片(Pravastatin Sodium Tablets) 商品名:普拉固片(Pravachol Tablets) 特 点:本品为3-羟基3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶)的竞争性抑制剂,HMG-CoA还原酶是胆固醇生物合成初期阶段的限速酶,本品可逆性地抑制HMG-CoA还原酶,从而抑制胆固醇的生物合成。 普拉固是目前世界上研究最为广泛,临床应用获得经验最多的降血脂药。在一系列临床试验中,对有高胆固醇血症的冠心病病人能降低心血管事件危险,减缓动脉粥样硬化的进展。西苏格兰冠心病预防研究(WOS试验)证实,普拉固能降低无冠心病的高胆固醇病人第一次心肌梗塞及死亡的危险。其出色
Name: Pravastatin Sodium Tablets Trade Name: Pravachol Tablets Features: This product is 3-hydroxy 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) As a competitive inhibitor, HMG-CoA reductase is a rate-limiting enzyme in the early stage of cholesterol biosynthesis. This product reversibly inhibits HMG-CoA reductase and thus inhibits cholesterol biosynthesis. Pulai solid is currently the world’s most widely studied, clinical application of the most experienced lipid-lowering drugs. In a series of clinical trials, coronary heart disease patients with hypercholesterolemia can reduce the risk of cardiovascular events and slow the progression of atherosclerosis. Western Scotland Coronary Prevention Study (WOS) confirmed that Pareclaide reduces the risk of first myocardial infarction and death in hypercholesterolemic patients without coronary heart disease. It’s excellent